Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial (Q61716563)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on 16 November 2011
Language Label Description Also known as
English
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
scientific article published on 16 November 2011

    Statements

    title
    Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    22089058
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22089058%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    16 January 2020
    author name string

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q61716563&oldid=1756757072"